Devin C. Koestler

University of Kansas Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

50h-index11.7kcitations481works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(231), Bladder and Urothelial Cancer Treatments(58), RNA modifications and cancer(41), Birth, Development, and Health(35), Inflammatory Biomarkers in Disease Prognosis(26)

Publications481 total

Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism
2026
A stochastic approach to k-nearest neighbors search using a fixed radius method
Computational Statistics·2026Open Access
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer
Cancer Immunology Immunotherapy·2025Open Access
Supplementary Table S5 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Table S2 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Table S3 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Figure S2 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Table S6 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Figure S4 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Figure S5 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Figure S1 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Table S1 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Figure S3 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Supplementary Table S4 from Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes
2025Open Access
Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survival
iScience·2025Open Access
Inferring absolute counts from proportions by constraining multivariate normal distributions
2025Open Access
Utilizing natural language processing to identify cancer-relevant publications at a National Cancer Institute-designated cancer center
JAMIA Open·2025Open Access
1123 Methylation cytometry enhances prediction of immunotherapy response in head and neck cancer
Regular and Young Investigator Award Abstracts·2025Open Access
Proton FLASH Exposure Preserves Gut Commensal Microbiomes and Spares Intestinal Stem Cells
2025Open Access
GDF-15 - Implications for Bladder Cancer Care and Symptom Control
Journal of the Academy of Nutrition and Dietetics·2025
page 1 of 25Next →

Frequent Co-authors

Carmen J. Marsit(24), Karl T. Kelsey(21), Brock C. Christensen(17), E. Andrés Houseman(16), Margaret R. Karagas(13), John K. Wiencke(11), Stefan Graw(6), David A. Armstrong(6), Heather H. Nelson(4), Lucas A. Salas(4), Rondi A. Butler(4), Scott M. Langevin(4), James F. Padbury(4), Alison G. Paquette(4), Barry M. Lester(4), Corina Lesseur(4), Helen M. Hansen(3), Juliette C. Madan(3), Molly L. Housman(3), Jason H. Moore(3)